Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Eli Lilly (NY:LLY)

924.37 -13.07 (-1.39%)
Official Closing Price Updated: 7:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,388,310
Open 931.17
Bid (Size) 923.53 (40)
Ask (Size) 924.00 (80)
Prev. Close 937.44
Today's Range 900.90 - 932.00
52wk Range 623.78 - 955.46
Shares Outstanding 956,580,893
Dividend Yield 0.65%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Organon (OGN) Reports Earnings Tomorrow: What To Expect
Pharmaceutical company Organon (NYSE:OGN) will be announcing earnings results this Monday before market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Eli Lilly And These AI Plays Lead 5 Stocks Near Buy Points
Eli Lilly stock and a pair of AI plays lead this watch list of stocks near buy points as the S&P 500 makes a stand at a key support level. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks

Performance

YTD
+18.8%
+18.8%
1 Month
+8.1%
+8.1%
3 Month
+45.5%
+45.5%
6 Month
+22.3%
+22.3%
1 Year
+11.2%
+11.2%

More News

Read More
This Unstoppable Growth Stock Just Gave Investors More Reasons to Buy
Via The Motley Fool
Prediction: Eli Lilly Will Be Worth More Than Berkshire Hathaway by 2030
Via The Motley Fool
Trump Announces Deals With Eli Lilly, Novo Nordisk To Lower Obesity Drug Prices
Via Stocktwits
Topics Government
Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for Investors.
Via The Motley Fool
Topics Government
Pfizer Clinches $10 Billion Deal To Buy Obesity Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance
Via Benzinga
Why Novo Nordisk Stock Is Sinking This Week
Via The Motley Fool
Topics Government World Trade
Why Nvidia (NVDA) Stock Is Falling Today
Via StockStory
Topics Artificial Intelligence
S&P 500: The Bull Market Is Just Getting Started
Via MarketMinute
Topics Artificial Intelligence Economy Energy
Eli Lilly's Investigational Obesity Drug Shows Up To 20% Weight Loss In Phase 2 Study, Analyst Sees It As Emerging Cornerstone In Obesity Treatment
Via Benzinga
Navigating the Shifting Tides: Experts Chart Course for 2025 Stock Market
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
FDA Fast-Tracks 6 More Drugs - Obesity And Cancer Drugs Included
Via Benzinga
Eli Lilly’s Weight-Loss Drug Mounjaro Becomes India’s Top-Selling Medicine By Value: Report
Via Stocktwits
Topics Government
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
Via Investor's Business Daily
Topics Government
Eli Lilly Stock Defies Trump’s GLP-1 Pricing Pressure With 6-Day Rally As Wall Street Cheers FDA Boost And New Weight-Loss Drug Data
Via Stocktwits
Topics Government World Trade
Can Hims & Hers Keep Its GLP-1 Edge After Trump Forces Lilly And Novo To Slash Prices? Wall Street Isn’t Convinced
Via Stocktwits
Topics Government World Trade
Eli Lilly Crushed Novo In Obesity Drug Battle—Trump Now Forces Price Cuts
Via Benzinga
Topics Government
Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx
Via Benzinga
Topics Government
Novo Nordisk Has Downgraded Its Outlook for the Fourth Time This Year. Here's What Investors Need to Know.
Via The Motley Fool
Topics Earnings
Trump Slashes Weight-Loss Drug Prices By Up To 74% In Deal With Lilly, Novo
Via Investor's Business Daily
Topics Government
Navigating the Volatility: Q3 2025 Earnings Season Delivers Both Cheers and Concerns
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
Via MarketMinute
Topics Intellectual Property
My 6 Top-Ranked Stocks to Buy Right Now in November
Via The Motley Fool
Topics Artificial Intelligence
Trump Administration's Weight-Loss Drug Deal Is Sending This Novo Nordisk Rival Surging: Momentum Score Spikes
Via Benzinga
Topics Government

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 924.37
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 11/07/25 07:00 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 884.23B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 884B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.